CTOs on the Move

Sientra

www.sientra.com

 
Headquartered in Santa Barbara, California, Sientra offers leading transformative treatments and technologies focused on progressing the art of plastic surgery and making a difference in patients` lives. With unrivaled safety, state-of-the-art science and exceptional service; paired with unparalleled partnerships with plastic surgeons, the Sientra portfolio of proprietary innovations radically advances how plastic surgeons think, work and care for their patients. The company`s core breast products segment includes its state-of-the-art Sientra breast implants and its ground-breaking dual-port breast tissue expander, AlloX2® . In addition, the Sientra portfolio also includes BIOCORNEUM® the #1 performing, preferred and recommended scar gel of plastic surgeons(*) ...
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.sientra.com
  • 420 South Fairview Avenue Suite 200
    Santa Barbara, CA USA 93117
  • Phone: 805.562.3500

Executives

Name Title Contact Details

Funding

Sientra raised $115M on 06/11/2019
Sientra raised $36.5M on 02/09/2021

Similar Companies

UMC

UMC is a Aurora, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Planmeca USA

Planmeca USA, a leading manufacturer of dental imaging and CAD/CAM equipment, recently moved its North American headquarters to a larger, high-tech facility that will house advanced training and facilitate innovation.

Invacare

Since 1885, Invacare has helped people with disabilities live life. Today, Invacare is the global leader in home and long-term-care medical products. Invacare Corporation (NYSE: IVC), headquartered in Elyria, Ohio, is the global leader in the manufacture and distribution of innovative home and long-term care medical products that promote recovery and active lifestyles. Invacare employs approximately 4,700 associates and markets its products in 80 countries around the world. The Company is listed on the New York Stock Exchange under the symbol IVC.

Portal Instruments

Portal Instruments is transforming the delivery of modern medicines and enhancing the standard of care for chronic diseases. Portal`s unique platform technology is capable of injecting today`s new biological drugs, regardless of volume or viscosity, with minimal sensation and time, providing the patient with enabling connectivity to optimize their disease challenges. The computer-controlled delivery technology is silent, innocuous, and highly customizable across a large variety of medical, animal, agricultural, and cosmetic applications.

Nextremity Solutions

Nextremity Solutions, Inc. is a privately held strategic commercialization organization with a focus on the musculoskeletal space, offering innovative solutions and Revenue Ready® products for various musculoskeletal applications and for the benefit of our industry partners. The Companys procedure-ready, sterile implant systems include uniquely precise, proprietary technology designed to achieve repeatable and superior clinical outcomes.